ong term study of AJG533 in patients with chronic constipatio
Phase 3
- Conditions
- Chronic constipation
- Registration Number
- JPRN-jRCT2080223007
- Lead Sponsor
- EA Pharma Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
Patients with chronic constipation
Exclusion Criteria
Patients with known or suspected organic constipation
Patients with known or suspected symptomatic constipation or drug-induced constipation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse Event
- Secondary Outcome Measures
Name Time Method Spontaneous Bowel Movement<br>Complete Spontaneous Bowel Movement